Back

An international multicenter clustered randomized trial to IMProve treatment with oral AntiCoagulanTs in Atrial Fibrilation.

28 August 2017 (16:05 - 16:25)
Organised by:
Congress Presentation Part of: Meet the Trialists - IMPACT-AF Atrial fibrillation (AF) ESC Premium Access ESC Congress 2017

About the speaker

Photo
Professor Christopher B Granger

Duke University Medical Center, Durham (United States of America)

Access the full session

Session thumbnail
Meet the Trialists - IMPACT-AF

The Event

Event poster

ESC Congress 2017

28 August 2017 16:05 CET
You may be interested in
thumbnail
Congress Presentation
Motivational Interviewing to Support Oral AntiCoagulation adherence in patients with non-valvular Atrial Fibrillation (MISOAC-AF): a randomised clinical trial
31 August 2020
thumbnail
Congress Presentation
Cluster-specific risk factors for suboptimal thromboprophylaxis in contemporary European cohort of patients with atrial fibrillation: the EHRA-PATHS Project
1 September 2024
thumbnail
Congress Presentation
Comparative efficacy and safety of antithrombotic regimens following left atrial appendage occlusion therapy in atrial fibrillation patients: a comprehensive Bayesian network meta-analysis
4 April 2025
thumbnail
Congress Presentation
One-year outcomes of inappropriate DOAC dosing in patients with atrial fibrillation
21 March 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources